Connect Biopharma Holdings Ltd (CNTB) stock
CNTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.58−0.06 (-9.98%)
Close on Nov 17, 2026Market cap $36.45MP/E –Yield –
Connect Biopharma total assets
Total assets on the balance sheet at the end of each period.
Connect Biopharma's total assets was $43.47M at Jun 30, 2026. For fiscal 2025 it was $56.08M, down 44.6% from the year before. The highest annual figure on record is $291.05M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $56.08M | -44.6% |
| FY2024 | Dec 31, 2024 | $101.28M | -20.5% |
| FY2023 | Dec 31, 2023 | $127.38M | -26.8% |
| FY2022 | Dec 31, 2022 | $174.01M | -40.2% |
| FY2021 | Dec 31, 2021 | $291.05M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $43.47M | -47.4% |
| Q1 FY2026 | Mar 31, 2026 | $60.07M | -35.2% |
| Q4 FY2025 | Dec 31, 2025 | $56.08M | -44.6% |
| Q3 FY2025 | Sep 30, 2025 | $67.36M | -44.1% |
| Q2 FY2025 | Jun 30, 2025 | $82.73M | -35.1% |
| Q1 FY2025 | Mar 31, 2025 | $92.69M | -35.7% |
| Q4 FY2024 | Dec 31, 2024 | $101.28M | -41.8% |
| Q2 FY2024 | Jun 30, 2024 | $120.57M | -48.6% |
| Q4 FY2023 | Dec 31, 2023 | $127.38M | -56.2% |
| Q2 FY2023 | Jun 30, 2023 | $144.08M | – |
| Q4 FY2022 | Dec 31, 2022 | $174.01M | – |
| Q2 FY2022 | Jun 30, 2022 | $234.70M | – |
| Q4 FY2021 | Dec 31, 2021 | $291.05M | – |
See a number that looks wrong?